Medscape Medical NewsAll articles

HeartKey® Rhythm

B-Secur Limited • Cardiovascular • 08/16/2024

510(k)IEC 62304 Class C§524B Cyber Device
FDA Summary PDF

Device Purpose

HeartKey® Rhythm is an advanced software library designed to assist healthcare professionals by automatically analyzing single-lead adult ECG data for cardiac arrhythmias. It utilizes a combination of rules-based calculations and AI/ML algorithms, integrated via an API into existing healthcare platforms, to perform ECG signal conditioning, beat detection, and rhythm classification.

Summary

HeartKey® Rhythm is a software library designed for qualified healthcare professionals to analyze single-lead electrocardiogram (ECG) data from adult patients. It is intended for integration via an Application Programming Interface (API) into various ECG management systems, analysis platforms, or remote patient monitoring platforms. The system processes ambulatory ECGs from devices like Holters, ECG patches, and event recorders, providing capabilities such as ECG signal conditioning to reduce noise, ECG signal quality assessment, QRS beat detection, and ventricular ectopic beat detection. Its primary function is to automatically analyze ECG data and aid in the assessment of cardiac arrhythmias, offering results on an advisory basis to supplement clinical judgment. The device operates using a combination of rules-based calculations and artificial intelligence/machine learning (AI/ML) technology to process and analyze ECG signals. Its features include a Signal Processing Engine for conditioning and beat detection, and an Arrhythmia Analysis module for identifying rhythms like Normal Sinus Rhythm, Atrial Fibrillation, Cardiac Pause, Tachycardia, and Bradycardia, as well as classifying beat types and providing heart rate. Non-clinical performance testing was conducted using a large proprietary dataset of over 1200 ECGs and standard databases, evaluating metrics such as sensitivity, specificity, and positive predictive values against clinically relevant acceptance criteria. This testing confirmed the software met its design requirements and demonstrated acceptable performance in ECG analysis, including successful cybersecurity assessments.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

ECG analysisArrhythmia detectionAI/MLSoftware libraryAPI integrationSignal processingQRS detectionVentricular ectopic beatHolter monitoringAmbulatory ECG

Device Metadata

Submission Number
K233755
Company
B-Secur Limited
Panel
Cardiovascular
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
detection/diagnosis

Relevant Clinical Questions

  • Q1. What specific AI/ML algorithms are employed by HeartKey® Rhythm, and how were they trained and validated beyond the proprietary dataset mentioned?; How does the single-lead analysis of HeartKey® Rhythm compare in diagnostic accuracy for specific arrhythmias (e.g., Atrial Fibrillation, Ventricular Ectopics) against traditional multi-lead ECG analysis systems?; What are the defined thresholds and criteria for "ECG signal quality assessment," and how does the system handle segments classified as "Unreadable" or "Inconclusive"?; Can the HeartKey® Rhythm API be customized by integrators to prioritize or flag certain types of arrhythmias based on specific clinical needs or patient populations?; What were the specific sensitivity, specificity, and positive predictive values achieved during the non-clinical testing for each of the detectable arrhythmias (Normal Sinus Rhythm, Atrial Fibrillation, Cardiac Pause, Tachycardia, Bradycardia)?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score80/100
SBOM Evidence✓ Detected in Summary
Cyber Risk Assessment✓ Detected in Summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials(software library)
✓ Detected
ML-BOMMachine Learning Bill of Materials(machine learning, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(remote, platform)
✓ Detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of SBOM, ML-BOM, SaaSBOM detected in AI-generated device summary.

• Not detected in AI-generated device summary: HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
HeartKey® Rhythm - B-Secur Limited | ESL FDA AI Device Intelligence